Chicago's Seurat Therapeutics raised $750K to treat migraines with a nasal spray
March 28, 2018 at 21:00 PM EDT
Seurat Therapeutics, a Chicago biotech startup that’s developing a nasal spray to treat and prevent migraines, has raised its first round of funding that will allow the company to begin testing their product in human clinical trials.
